Many health systems have used hospital consolidations or physician group acquisitions to grow and compete. But these actions often come at the expense of rising healthcare and insurance costs for patients, says the AHIP.
It would seem obvious that the continued pandemic is driving up healthcare costs in America. But there may be other significant factors at play, including the ongoing trend of hospital consolidations, mergers, and acquisitions (M&A).
Many health systems have been joining forces over the past few years, or simply acquiring smaller hospitals that are facing financial hardship. Traditionally, health systems look for complimentary systems or hospitals that fill in gaps in their services and resources. But they also look for low-hanging fruit—too-good-to-pass-up opportunities that present themselves.
Such consolidations are usually intended to drive costs down. But whether that is the case or not, savings aren't being passed on to the typical consumer, argues David Allen, a spokesperson at AHIP (America's Health Insurance Plans) trade association.
If Allen is correct, that is bad news. This trend is a main factor in the growing healthcare costs for the typical American, he says, and it shows no sign of slowing.
"Hospitals continue to consolidate. Even the pandemic did not significantly slow this trend," Allen says. "A number of experts are predicting a further increase in the rate of such consolidation post-pandemic."
Allen takes issue with arguments by some that consolidations or M&A lead to savings across the board.
"Hospitals have long promised such benefits. Unfortunately, studies (cited in AHIP's resources) have shown that these promises have not been realized. Therefore, it is unwise to allow the certainty of higher costs from anti-competitive hospital mergers based on the unrealized promise of efficiencies and improved care," Allen stresses.
It's not just health systems and individual hospitals that are targets. Just as attractive for acquisition are physician groups.
"Hospital consolidation is a main factor driving up healthcare costs for hard-working Americans. And hospitals continue to put profits before patients by buying up physician practices," Allen continues. "When hospitals increase market share through physician practice acquisition, they can control referrals and demand higher prices, which, in turn, makes premiums and costs for everyone even higher."
The AHIP is not alone in this view. As recently noted in a statement by the director of public affairs for the Federal Trade Commission, "Too many hospital mergers lead to jacked up prices and diminished care for patients most in need."
Consolidation and acquisitions are just what the doctor order, says EY
Should we be worried about the continued trend of hospital consolidations and physician group acquisitions? Not at all, says consulting firm Ernst & Young (EY).
"As hospitals increasingly face significant margin challenges driven by an ever-increasing cost of care and a relentless pressure to reduce reimbursement for those care costs, M&A has an ever-important role to play," EY noted of the barometer findings. "In fact, only the largest hospitals, with operating margins averaging 6.6%, have comparable margins to the largest US payers (which ranged from 5.0% to 8.1% in 2019). The rest of hospitals actually had negative operating margins in 2019."
EY recently completed its Global Capital Confidence Barometer, which looks at the number of healthcare executives that are, or are contemplating, doing a M&A in the next 12 months. The barometer did show a decline in consolidations during the current pandemic surges, but the firm expects the number to pick up again as we emerge from the pandemic.
Even in good times, the healthcare industry is under tremendous pressure to keep costs down while keeping patient care and patient satisfaction up. COVID-19 made everything much worse, says Simon Joyeux, EY's U.S.-East health sciences and wellness strategy and transactions leader.
"Everyone's fighting for resources. There isn't a level playing field, and there are a lot of players in and outside the industry that are trying to change the way we deliver healthcare," Joyeux explains. "COVID added more pressure. So, can the industry stay the way it has been, or is M&A the prescription that will help those hospitals continue to be competitive?"
EY believes that is the case, and the consulting firm says there are three factors that could make consolidations or mergers more appealing going forward:
Hospital margins are shrinking
Vertical integration between payers and providers
The need for hospital systems to scale to compete
Patient care hasn't improved with this trend, despite many promises
The bottom line on whether a trend is beneficial in healthcare or not is, ultimately, how it impacts patients. And by that measure, hospital consolidations and physician group acquisitions are just plain bad medicine, Allen stresses.
"Patient care does not appear to have improved as a result of consolidations. Moreover, the proposition that hospitals should be allowed to gain market power and increased prices based on unproved promises of better care is problematic," Allen says. "Our members have worked, and continue to work, with hospital and physician partners on approaches to improving care and efficiency that don't require anti-competitive consolidations."
But one might assume that when health systems merge, they can simplify many operational practices that should produce cost reductions, right? Apparently not, according to the AHIP.
"According to one study, hospital consolidation has been linked to average annual marketplace insurance premiums that are 5% higher than those in less concentrated areas," the AHIP noted in an August 26 blog. Another study looked at hospital prices for those with employer-provided health coverage. It found that hospitals that do not have any competitors within a 15-mile radius have prices that are 12% higher than markets with four or more competing hospitals. When looking at the average amount of Americans' premium dollars that go to hospitals—a whopping 42%—that 12% hospital non-competition surcharge results in an average increase of over $1,000 per year for families and over $370 per year for individuals enrolled in employer-sponsored health plans."
It's a similar problem with physician group acquisitions, the AHIP explained in a separate blog. According to the association:
Prices for services provided by acquired physicians increased by an average of 14.1%, concluded a study published by the Journal of Health Economics.
"Vertical relations can be a way for physicians and hospitals to bundle their services together and charge insurers higher prices, according to research published by Health Affairs.
"The average price for a given service was always higher when performed in an outpatient setting. Average prices also tended to grow faster for the same services when performed in outpatient settings compared to office settings," the Health Care Cost Institute found.
Most organizations and individuals are leery of government intervention in industry dilemma, but that is exactly what is needed, Allen says.
"More enforcement by federal and state agencies is an important part of the solution," Allen says. "So, too, is increased enforcement against anti-competitive ways in which already-consolidated hospital systems exercise market power."
The former CFO at Iowa Health Care starts a new role in one of the country's leading health systems, as it looks to evolve and change to meet new patient needs.
On August 17, Brad Haws was appointed chief financial officer at Emory Healthcare in Georgia, part of Emory University, and one of the leading health systems in the country.
Haws joins the healthcare system from the University of Iowa Health Care, where he was associate vice president and CFO. Before that, he spent 13 years in the University of Virginia health system, including leadership stints in its healthcare group and its school of medicine. Earlier in his career, he was the CFO at Intermountain Healthcare.
U.S. News & World Report has ranked Emory University Hospital the No. 1 hospital in Georgia and metro Atlanta in its 2020–2021 Best Hospitals guide, and bestowed that honor on the hospital for nine years in a row. (Emory University Hospital includes Emory University Orthopaedics & Spine Hospital and Emory University Hospital at Wesley Woods.)
The medical staff at Emory Healthcare have likewise been honored repeatedly in top rankings. Almost half of the physicians recognized in the 2021 "Top Doctors" issue of Atlanta magazineare physicians within Emory Healthcare or Emory Healthcare Network, Emory medical staff, or faculty of Emory University School of Medicine.
HealthLeaders had the opportunity to catch up with Brad Haws and ask him about his goals in this new role, and his advice to other healthcare executives on how health systems can thrive in these turbulent times.
HealthLeaders: Tell us a little bit about Emory Healthcare and the community it serves.
Brad Haws: Emory Healthcare, part of Emory University, is the most comprehensive, academic health system in Georgia. We are comprised of 11 hospitals, the Emory Clinic, and more than 250 provider locations. The Emory Healthcare Network, established in 2011, is the largest clinically integrated network in Georgia, with more than 2,800 physicians concentrating in 70 different subspecialties.
Emory Healthcare is an integrated academic medical center committed to providing the best care for our patients, educating health professionals and leaders for the future, pursuing discovery research in all its forms, including basic, clinical, and population-based research, and serving our community. As the clinical enterprise of the Robert W. Woodruff Health Sciences Center of Emory University, Emory Healthcare is dedicated to the unifying core purpose, core values, and strategic direction of the Robert W. Woodruff Health Sciences Center.
HealthLeaders: What are your primary responsibilities in this role, and what is it about your background and experiences that makes your recent appointment a mutually good fit for both you and the organization?
Haws: I am in charge of the normal financial functions with the healthcare environment but view my role of being a partner to the other members of the leadership team as my primary role. The role of finance has evolved so that we are an integral part of successful operations and strategy development/implementation.
I have spent most of my career in academic healthcare in a variety of roles and settings. The experiences I have gained will be useful to the organization and its missions. Balancing the tripartite missions can be challenging, and I look forward to working with the incredible team here to meet the challenge.
HealthLeaders: Aside from the pandemic, what do you believe are the top three challenges facing healthcare organizations today?
Haws: The nature of our services is evolving—the patients have always wanted excellent life-saving care and service, but now may expect that it is delivered in a different fashion. Telehealth is one simple example of that evolution.
Our ability to evolve and change will determine our future success. We are always looking to manage cost, quality, and access, but those are simple fundamentals of the business. Competition, consolidation, cost pressures are ongoing areas that must be managed. Lately, staffing challenges associated with the pandemic are probably one of our most pressing issues.
HealthLeaders: What goals do you want to achieve in this CFO role, and have you been asked to lead or meet any specific missions?
Haws: I am still very new in the role but am thrilled to be part of the senior team that is working on a variety of projects.
I want to be a value-added partner to the overall success of the organization. Sometimes, finance can get lulled into sitting back and evaluating/reporting "balls and strikes." My goal is to roll up my sleeves and partner with the great team here and to be part of the solutions to our challenges.
HealthLeaders: In what ways can CFOs help health systems, hospitals, and the healthcare industry plan for an uncertain and turbulent future?
Haws: Solid financial performance allows for a couple of things. It gives degrees of freedom to work on different solutions. Not all efforts succeed, but when financials are tight or less secure, those plans or bets take on added significance.
Managing the risks associated with the various challenges we face often comes with a need for information and data. While not perfect, analyzing and projecting potential impacts and sensitivities is a vital part of our role in finance.
HealthLeaders: What advice do you have for other healthcare CFOs on how to best help their organizations succeed at serving patients, nurturing staff, mastering efficiencies, and surpassing the competition?
Haws: Define relative metrics, benchmarks, and goals and manage to them. If there are gaps, work on plans to close the gaps. Lean management (called Empower here at Emory) is the best way to implement change and test potential solutions. Trending not only against our past but against our peer groups is a vital way to measure and define success.
Brad Haws is a HealthLeaders Exchange member. The HealthLeaders Exchange is an executive community for sharing ideas, solutions, and insights. Please join the community at https://www.linkedin.com/company/
healthleaders-exchange/. To inquire about attending a HealthLeaders Exchange, email us at exchange@healthleadersmedia.com.
One consulting firm offers three factors that could support hospital M&A strategies in 2021 and beyond.
The human toll that COVID-19 is taking is painfully obvious, always heartbreaking, and often inspiring. But could the pandemic also put some hospitals on life-support, as it greatly reduces consolidation strategies within the industry, and with that, the ability for hospitals to cut losses?
That is the view of consulting firm Ernst & Young (EY), which recently completed its Global Capital Confidence Barometer and discovered a dramatic drop in the number of healthcare executives that are contemplating a merger or acquisition in the next 12 months.
According to EY, 34% of healthcare executives now say they plan to pursue M&A through next year. That number is significantly down from the 60% that made the same claim a year ago. Whether this is good news or bad depends on who you ask, but according to EY, it could have impacts on the long-term outlook of healthcare organizations.
"As hospitals increasingly face significant margin challenges driven by an ever-increasing cost of care and a relentless pressure to reduce reimbursement for those care costs, M&A has an ever-important role to play," EY noted of the barometer findings. "In fact, only the largest hospitals, with operating margins averaging 6.6%, have comparable margins to the largest US payers (which ranged from 5.0% to 8.1% in 2019). The rest of hospitals actually had negative operating margins in 2019."
Despite the current decline in M&A interest, EY cites three major factors that could support hospital M&A strategies in 2021 and beyond. They are:
Hospital margins are shrinking. "The average hospital operating margin fell to 0.3% in 2019 from 1.8% in 2015. To combat this, ratcheting up hospital M&A can lower costs and increase margins through economies of scale, capture broader patient volumes, enhance coordination of care delivery across the care continuum, and develop sustainable reimbursement solutions with managed care and corporate payers," the firm noted.
Vertical integration between payers and providers. "In the long run, convergence may be critical to enable the US to break away from the 'pay for volumes' paradigm. In the meantime, health systems and payers can work together to find solutions that can work for sustainable economics today and bridge to tomorrow," EY stated.
The need for hospital systems to scale to compete. "Consolidation of hospital peers or systems may reduce costs by increasing scale. M&A, with an academic medical center, can allow a health system to increase its scale and improve its regional brand presence as a provider of world-class, innovative care," the consulting firm states.
But not everyone agrees that M&As are the right tourniquet for stopping the financial bleeding at many hospitals. Indeed, the AHIP (America's Health Insurance Plans) trade association says that one of the main drivers of rising healthcare costs is the increasing consolidation among hospitals and hospital systems. The Federal Trade Commission shares that view.
"Too many hospital mergers lead to jacked up prices and diminished care for patients most in need," the commission noted in a statement last month.
In a separate blog by the AHIP in August, the association noted that "Arguments in favor of hospital consolidation often tout higher quality of care or other benefits for consumers. A number of recent studies have found this to be untrue. According to a study on hospital mergers and acquisitions in 2009-2013, 'Hospital acquisition by another hospital or hospital system was associated with modestly worse patient experiences and no significant changes in readmission or mortality rates.' "
Desperate times, and desperate measures
Even in good times, the healthcare industry is under tremendous pressure to keep costs down while keeping patient care and patient satisfaction up. COVID-19 made everything much worse, says Simon Joyeux, EY's U.S.-East health sciences and wellness strategy and transactions leader.
"Everyone's fighting for resources. There isn't a level playing field, and there are a lot of players in and outside the industry that are trying to change the way we deliver healthcare," Joyeux explained. "COVID added more pressure. So, can the industry stay the way it has been, or is M&A the prescription that will help those hospitals continue to be competitive?"
In addressing that question, EY consultants developed a six-step process to help financially challenged hospitals decide whether consolidation is just what the doctor ordered.
Think of step one as the equivalent of a financial check-up, Joyeux explains. The check-up starts with three questions that the leader should ask to determine the organization's ability to do a deal, and if so, the size and scale of the deal that is right. Those questions are:
What is their equity?
How much cash do they have at their disposal?
What is their debt capacity and how much can they draw on that?
Step two is looking at the competitive dynamics in the market. This includes evaluating the choices that patients are making for where they seek care, and how care is being delivered.
Step three is the reimbursement dynamic. Healthcare organizations need to know whether they are in a market where payers are consolidating, or at risk of consolidating, and how either could impact pricing power.
Step four is looking at the patient demographics in the local market. Is the population growing, shrinking, aging or getting younger, getting sicker or less sick, and how these factors will impact the type of services needed in the future.
Step five is evaluating whether there is a trend to more outpatient versus inpatient services needed, and how your organization stacks up in meeting that trend.
Step six is looking at your competitors and evaluating what new opportunities there might be in the local market based on gaps in current services.
There is no one-size-fits-all formula for making the decision to pursue consolidation.
"The criteria for each hospital will be different," Joyeux stresses. "They'll be specific to the hospital. Every market is going to be different. It's very much a local business. So, the challenges and the opportunities for hospitals in Nebraska will be wildly different than a hospital in the New York area."
Finally, Joyeux says hospitals need to be clear on what they're trying to accomplish with a consolidation. A merger should cut costs and streamline operations. But it should also enhance the quantity and quality of healthcare services the organization can provide.
David Weldon is a contributing writer for HealthLeaders.